{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:59:57Z","timestamp":1773291597508,"version":"3.50.1"},"reference-count":44,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[1996,6,1]]},"DOI":"10.1136\/bjo.80.6.549","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:53:19Z","timestamp":1190152399000},"page":"549-552","source":"Crossref","is-referenced-by-count":40,"title":["Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid."],"prefix":"10.1136","volume":"80","author":[{"given":"M. J.","family":"Elder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Dart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.1971.04000230009002","article-title":"Benign mucous membrane pemphigoid","volume":"104","author":"Hardy, K.M.; Perry, H.O.; Pingree, G.C.","year":"1971","unstructured":"Hardy KM, Perry HO, Pingree GC. Benign mucous membrane pemphigoid. Arch Dermatol 1971;104:467-75.","journal-title":"Arch Dermatol"},{"key":"ref_2","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster, C.S.","year":"1986","unstructured":"Foster CS. Cicatricial pemphigoid. TransAm Ophthalmol Soc 1986;84:527-663.","journal-title":"TransAm Ophthalmol Soc"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0161-6420(90)32479-X","article-title":"Cicatricial pemphigoid and erythema multiforme","volume":"97","author":"Mondino, B.J.","year":"1990","unstructured":"Mondino BJ. Cicatricial pemphigoid and erythema multiforme. Ophhalwmology 1990;97:939-52.","journal-title":"Ophhalwmology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0161-6420(79)35486-0","article-title":"The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment","volume":"86","author":"Mondino, B.J.; Brown, S.I.; Lempert, S.; Jenkins, M.S.","year":"1979","unstructured":"Mondino BJ, Brown SI, Lempert S, Jenkins MS. The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. Ophtalmology 1979;86:543-52.","journal-title":"Ophtalmology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino, B.J.; Brown, S.I.","year":"1981","unstructured":"Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology 1981;88:95-100","journal-title":"Ophthalmology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.1989.tb07769.x","article-title":"Dapsone as first line therapy for bullous pemphigoid","volume":"120","author":"Venning, V.A.; Millard, P.R.; Wojnarowska, F.","year":"1989","unstructured":"Venning VA, Millard PR, Wojnarowska F. Dapsone as first line therapy for bullous pemphigoid. Br J Dermawl 1989;120:83-92.","journal-title":"Br J Dermawl"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00561449","article-title":"Electron microscopic studies in dermatitis herpetiformis in relation to the pattern of immune deposits in the skin","volume":"259","author":"Dabrowski, J.; Jablonska, S.; Chorzelski, T.P.; JarzabekChorzelska, M.; Maciejewski, W.","year":"1977","unstructured":"Dabrowski J, Jablonska S, Chorzelski TP, JarzabekChorzelska M, Maciejewski W. Electron microscopic studies in dermatitis herpetiformis in relation to the pattern of immune deposits in the skin. Arch Dermatol Res 1977;259: 213-24.","journal-title":"Arch Dermatol Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/bmj.290.6481.1535","article-title":"Which component of sulphasalazine is active in rheumatoid arthritis?","volume":"290","author":"Pullar, T.; Hunter, J.A.; Capell, H.A.","year":"1985","unstructured":"Pullar T, Hunter JA, Capell HA. Which component of sulphasalazine is active in rheumatoid arthritis? Br MedJ Clin Res Ed 1985;290:1535-8.","journal-title":"Br MedJ Clin Res Ed"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/rheumatology\/24.3.269","article-title":"Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy","volume":"24","author":"Pullar, T.; Hunter, J.A.; Capell, H.A.","year":"1985","unstructured":"Pullar T, Hunter JA, Capell HA. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. BrJRheumatol 1985;24:269-76.","journal-title":"BrJRheumatol"},{"key":"ref_10","first-page":"285","article-title":"A study to determine the active moiety of sulphasalazine in rheumatoid arthritis","volume":"13","author":"Neumann, V.C.; Taggart, A.J.; Le-Gallez, P.; Astbury, C.; Hill, J.; Bird, H.A.","year":"1986","unstructured":"Neumann VC, Taggart AJ, Le-Gallez P, Astbury C, Hill J, Bird HA. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 1986; 13:285-7.","journal-title":"J Rheumatol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-198600321-00006","article-title":"5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?","volume":"32","author":"Taggart, A.J.; Neumann, V.C.; Hill, J.; Astbury, C.; Le-Gallez, P.; Dixon, J.S.","year":"1986","unstructured":"Taggart AJ, Neumann VC, Hill J, Astbury C, Le-Gallez P, Dixon JS. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis? Drugs 1986;32 (suppl):27-34.","journal-title":"Drugs"},{"issue":"2","key":"ref_12","first-page":"1708","article-title":"Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis","volume":"1962","author":"Truelove, S.C.; Watkinson, G.","unstructured":"Truelove SC, Watkinson G. Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis. BMJ 1962; 2:1708-11.","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/bmj.2.6094.1057","article-title":"Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis","volume":"2","author":"Cowan, G.O.; Das, K.M.; Eastwood, M.A.","year":"1977","unstructured":"Cowan GO, Das KM, Eastwood MA. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. BMJ 1977;2:1057-9.","journal-title":"BMJ"},{"key":"ref_14","first-page":"1","article-title":"Sulphasalazine: a review of 40 years'","volume":"32","author":"Watkinson, G.","year":"1986","unstructured":"Watkinson G. Sulphasalazine: a review of 40 years' experience. Drugs 1986;32 (suppl): 1-l1.","journal-title":"experience. Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","article-title":"Immunosuppressive therapy in ocular cicatricial pemphigoid","volume":"96","author":"Mondino, B.J.; Brown, S.I.","year":"1983","unstructured":"Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 1983;96: 453-9.","journal-title":"Am J Ophthalmol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9394(77)90546-3","article-title":"Autoimmune phenomena in ocular cicatricial pemphigoid","volume":"83","author":"Mondino, B.J.; Ross, A.N.; Rabin, B.S.; Brown, S.I.","year":"1977","unstructured":"Mondino BJ, Ross AN, Rabin BS, Brown SI. Autoimmune phenomena in ocular cicatricial pemphigoid. Am J Ophthalmol 1977;83:443-50.","journal-title":"Am J Ophthalmol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0161-6420(82)34791-0","article-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","volume":"89","author":"Foster, C.S.; Wilson, L.A.; Ekins, M.B.","year":"1982","unstructured":"Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982;89:340-53.","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0161-6420(92)32001-9","article-title":"Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications","volume":"99","author":"Schwab, I.R.; Linberg, J.V.; Gioia, V.M.; Benson, W.H.; Chao, G.M.","year":"1992","unstructured":"Schwab IR, Linberg JV, Gioia VM, Benson WH, Chao GM. Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology 1992;99: 197-202.","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00003226-199105000-00001","article-title":"Systemic chemotherapy for ocular cicatricial pemphigoid","volume":"10","author":"Tauber, J.; Sainz de Ia Maza, M.; Foster, C.S.","year":"1991","unstructured":"Tauber J, Sainz de Ia Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991;10: 185-95.","journal-title":"Cornea"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1442-9071.1990.tb00605.x","article-title":"Ocular cicatricial pemphigoid","volume":"18","author":"Francis, I.C.; McCluskey, P.J.; Walls, R.S.; Wakefield, D.; Brewer, J.M.","year":"1990","unstructured":"Francis IC, McCluskey PJ, Walls RS, Wakefield D, Brewer JM. Ocular cicatricial pemphigoid. Aust NZJ Ophthalmol 1990;18:143-50.","journal-title":"Aust NZJ Ophthalmol"},{"key":"ref_21","first-page":"479","article-title":"Sulfones and sulfonamides in dermatology today","volume":"1","author":"Lang, P.G.","year":"1979","unstructured":"Lang PG. Sulfones and sulfonamides in dermatology today. JAmAcad Dermatol 1979;1;479-92.","journal-title":"JAmAcad Dermatol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","article-title":"Dapsone suppresses integrin-mediated neutrophil adherence function","volume":"98","author":"Booth, S.A.; Moody, C.E.; Dahl, M.V.; Herron, M.J.; Nelson, R.D.","year":"1992","unstructured":"Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992;98: 135-40.","journal-title":"J Invest Dermatol"},{"key":"ref_23","first-page":"215","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","year":"1982","unstructured":"Rogers RS m, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. JAmAcad Dermatol 1982;6:215-23.","journal-title":"JAmAcad Dermatol"},{"key":"ref_24","first-page":"335","article-title":"Long term complications of conventional immunosuppressive treatment","volume":"18","author":"Boitard, C.; Bach, J.F.","year":"1989","unstructured":"Boitard C, Bach JF. Long term complications of conventional immunosuppressive treatment. Adv Nephrol 1989; 18:335-54.","journal-title":"Adv Nephrol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archderm.1974.01630090031007","article-title":"Immunosuppressive and cytotoxic drugs in dermatology","volume":"110","author":"Dantzig, P.I.","year":"1974","unstructured":"Dantzig PI. Immunosuppressive and cytotoxic drugs in dermatology. Arch Dermatol 1974;110:393-406.","journal-title":"Arch Dermatol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.1992.tb04124.x","article-title":"Drug therapy of ulcerative colitis","volume":"34","author":"Crotty, B.; Jewel, D.P.","year":"1992","unstructured":"Crotty B, Jewel DP. Drug therapy of ulcerative colitis. Br J Clin Pharmacol 1992;34:189-98.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","article-title":"Clinical pharmacokinetics of sulphasalazine; its metabolites and other prodrugs of 5-amino salicylic acid","volume":"10","author":"Klotz, U.","year":"1985","unstructured":"Klotz U. Clinical pharmacokinetics of sulphasalazine; its metabolites and other prodrugs of 5-amino salicylic acid. Clin Pharmacokinet 1985;10:285-302.","journal-title":"Clin Pharmacokinet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.0954-6820.1977.tb15685.x","article-title":"Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases","author":"Molin, L.; Larsson, R.; Karlsson, E.","year":"1977","unstructured":"Molin L, Larsson R, Karlsson E. Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases. Acta Med Scand 1977;201:217-22.","journal-title":"Acta Med Scand"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2165\/00003495-198600321-00005","article-title":"Pharmacological and biochemical actions of sulphasalazine","volume":"32","author":"Hoult, JR","year":"1986","unstructured":"Hoult JR. Pharmacological and biochemical actions of sulphasalazine. Drugs 1986;32 (suppl):18-26.","journal-title":"Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/0006-2952(92)90315-A","article-title":"The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells","volume":"43","author":"Punchard, N.A.; Boswell, D.J.; Greenfield, S.M.; Thompson, R.P.","year":"1992","unstructured":"Punchard NA, Boswell DJ, Greenfield SM, Thompson RP. The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells. Biochem Pharmacol 1992;43:2369-76.","journal-title":"Biochem Pharmacol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/cs0690177","article-title":"Sulphasalazine and derivatives, natural killer activity and ulcerative colitis","volume":"69","author":"Gibson, P.R.; Jewell, D.P.","year":"1985","unstructured":"Gibson PR, Jewell DP. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis. Clin Sci 1985;69: 177-84.","journal-title":"Clin Sci"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2133.1989.tb08218.x","article-title":"Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid","volume":"121","author":"McFadden, J.P.; Leonard, J.N.; Powles, A.V.; Rutman, A.V.; Fry, L.","year":"1989","unstructured":"McFadden JP, Leonard JN, Powles AV, Rutman AV, Fry L. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989;121:759-62.","journal-title":"Br J Dermatol"},{"key":"ref_33","first-page":"551","article-title":"A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route","volume":"3","year":"1984","unstructured":"Ashworth M, Arthur M, Turmer AD, Smith PR. A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route. Pharmatherapeutica 1984;3:551-5.","journal-title":"Pharmatherapeutica"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1445-5994.1991.tb04705.x","article-title":"Pulmonary infiltrates and eosinophilia associated with sulphasalazine administration","volume":"21","author":"Panayiotou, B.N.","year":"1991","unstructured":"Panayiotou BN. Pulmonary infiltrates and eosinophilia associated with sulphasalazine administration. Aust NZ J Med 1991;21:348-9.","journal-title":"Aust NZ J Med"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archderm.1977.01640050070009","article-title":"Bullous pemphigoid responding to sulphapyridine and the sulphones","volume":"113","author":"Person, JR, Rodgers; R.S.","year":"1977","unstructured":"Person JR, Rodgers RS. Bullous pemphigoid responding to sulphapyridine and the sulphones. Arch Dermatol 1977; 113:610-5.","journal-title":"Arch Dermatol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archderm.1947.01520110060008","article-title":"Sulphapyridine in the treatment of dermatitis herpetiformis","volume":"56","author":"Costello, M.J.","year":"1947","unstructured":"Costello MJ. Sulphapyridine in the treatment of dermatitis herpetiformis. Arch Dermatol 1947;56:614-24.","journal-title":"Arch Dermatol"},{"issue":"82","key":"ref_37","first-page":"385","article-title":"HL Dermatitis herpetiformis with acantholysis or pemphigus with response to sulphonamides: report of two cases","volume":"1960","author":"Winkleman, R.K.; Roth","unstructured":"Winkleman RK, Roth HL Dermatitis herpetiformis with acantholysis or pemphigus with response to sulphonamides: report of two cases. Arch Dermatol 1960;82:385-90.","journal-title":"Arch Dermatol"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.1951.03670120017005","article-title":"Treatment of acne vulgaris","volume":"146","author":"Andrews, G.C.; Domonkos, A.N.; Post, C.F.","year":"1951","unstructured":"Andrews GC, Domonkos AN, Post CF. Treatment of acne vulgaris.JAAMA 1951;146:1107-11.","journal-title":"JAAMA"},{"issue":"40","key":"ref_39","first-page":"853","article-title":"Effect of treatment with sulphapyridine on acrodermatitis continua (Hallopeau)","volume":"1939","author":"Sulzberger, M.B.","unstructured":"Sulzberger MB. Effect of treatment with sulphapyridine on acrodermatitis continua (Hallopeau). Arch Dermatol Syphilol 1939;40:853-7.","journal-title":"Arch Dermatol Syphilol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2133.1968.tb12289.x","article-title":"Erythema elevatum diutinum-vascular lesions and sulphone response","volume":"80","author":"Vollum, D.I.","year":"1968","unstructured":"Vollum DI. Erythema elevatum diutinum-vascular lesions and sulphone response. BrJ Dermatol 1968;80:178-83.","journal-title":"BrJ Dermatol"},{"key":"ref_41","first-page":"665","article-title":"Allergic vasculitis (tri-symptom of Gougerot)","volume-title":"treated with dapsone. Proc R Soc Med 1969","volume":"62","author":"Wells, G.C.","unstructured":"Wells GC. Allergic vasculitis (tri-symptom of Gougerot) treated with dapsone. Proc R Soc Med 1969;62:665-6."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.1957.01550150066007","article-title":"Pyoderma gangrenosum: a clinical study of 19 cases","volume":"75","author":"Perry, H.O.; Brunsting, L.A.","year":"1957","unstructured":"Perry HO, Brunsting LA. Pyoderma gangrenosum: a clinical study of 19 cases. Arch Dermatol 1957;75:380-6.","journal-title":"Arch Dermatol"},{"issue":"80","key":"ref_43","first-page":"72","article-title":"Subcorneal pustular dermatosis","volume":"1959","author":"Burns, R.E.; Fine, G.","unstructured":"Burns RE, Fine G. Subcorneal pustular dermatosis. Arch Dermatol 1959:80:72-80.","journal-title":"Arch Dermatol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003495-198938020-00007","article-title":"Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy","volume":"38","author":"Hawthorne, A.B.; Hawkey, C.J.","year":"1989","unstructured":"Hawthorne AB, Hawkey CJ. Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy. Drugs 1989;38:267-88.","journal-title":"Drugs"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.80.6.549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T23:38:37Z","timestamp":1708213117000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.80.6.549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,6,1]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.80.6.549","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[1996,6,1]]}}}